DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Betamethasone acetate; betamethasone sodium phosphateis the generic ingredient in two branded drugs marketed by Am Regent and Merck Sharp Dohme, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.
There are sixty-six drug master file entries for betamethasone acetate; betamethasone sodium phosphate. Six suppliers are listed for this compound.
Recent Clinical Trials for betamethasone acetate; betamethasone sodium phosphate
Identify potential brand extensions & 505(b)(2) entrants
|Tel-Aviv Sourasky Medical Center||N/A|
|University of Kentucky||Early Phase 1|